Sponsor Pipeline

University of Oklahoma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
78
Active Trials
43
Recruiting
3
Phase 3
10
Disease Areas
16
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT07217574
Program in Oncology for Tribal Health Systems.
Phase changed: [] -> ['NA']
2026-06-02 NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
Trial terminated — check why_stopped for reason
2026-06-02 NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
critical why stopped: null → "Translational scientist left university"
2026-06-02 NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
Enrollment reduced: 60 -> 25 participants
2026-06-02 NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
date change Primary completion moved earlier: 2026-09 -> 2026-03-03
2026-06-02 NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
date change Completion moved earlier: 2027-09 -> 2026-04-03
2026-06-02 NCT05333978
Optoacoustic Detection of Inflammation Using MSOT Device
date change Completion moved earlier: 2028-05-01 -> 2026-04-20
2026-06-02 NCT05275075
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Trial terminated — check why_stopped for reason
2026-06-02 NCT05275075
Identify microRNAs in Cachexia in Pancreatic Carcinoma
critical why stopped: null → "Translational scientist left university"
2026-06-02 NCT05275075
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Enrollment reduced: 100 -> 40 participants
2026-06-02 NCT05275075
Identify microRNAs in Cachexia in Pancreatic Carcinoma
date change Completion moved earlier: 2029-05-01 -> 2026-04-03
2026-05-29 NCT07579455
Acute Pharmacokinetics of Create Wellness Gummies in Healthy Adults
Recruitment opened
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
overall status: "Recruiting" → "Active Not Recruiting"
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Enrollment increased: 13 -> 15 participants
2026-05-28 NCT05806814
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
date change Completion pushed: 2026-12 -> 2028-05-13
2026-05-20 NCT07494773
Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection
Phase changed: ['PHASE1', 'PHASE2'] -> ['EARLY_PHASE1']
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-08 NCT07631299 Nebulized AER101 in Pre-op NSCLC Early Phase 1 Not Yet Recruiting
2026-06-03 NCT07622914 The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer Recruiting
2026-05-15 NCT07591428 Reset Challenge: Reducing High-risk Drinking for Cancer Prevention Recruiting
Active Trials by Phase
Phase 4
4
Phase 3
1
Phase 2/3
2
Phase 2
14
Phase 1
8
Early Phase 1
7
Not specified
42
Active Trials — top 25 of 78
NCT IDTitleConditionStatus
Phase 4
NCT04248205 Ketamine for Post-operative Analgesia in Hemorrhoidectomy Hemorrhoids Recruiting
NCT05483465 The Effect of NAD Supplementation on Brain Vascular Health in Aging Aging Recruiting
NCT05587361 Beta-Adrenergic Modulation of Drug Cue Reactivity Tobacco Use Disorder Recruiting
NCT04831398 The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic… Healthy Active, Not Recruiting
Phase 3
NCT05174052 Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF) Diabetes Mellitus Recruiting
Phase 2/3
NCT06821295 Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing… Alcohol Misuse Recruiting
NCT06820034 Empowering Cessation ACS South Region Smoking Cessation Recruiting
Phase 2
NCT07183319 Circulating Tumor DNA Response In Urothelial Cancer Urothelial Carcinoma Recruiting
NCT06494150 Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) Low Grade Ovarian Serous Adenocarcinoma Recruiting
NCT07223541 Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell… Clear Cell Renal Cell Carcinoma Recruiting
NCT06488781 Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae… Obesity in Pregnancy Recruiting
NCT06296849 Dyadic Financial Incentive Treatments for Dual Smoker Couples Smoking, Cigarette Recruiting
NCT06129604 Pilot Window of Opportunity Trial (POET) Colorectal Carcinoma (CRC) Active, Not Recruiting
NCT04068753 Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive… Recurrent Cervix Cancer Active, Not Recruiting
NCT07099638 Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence… Smoking Cessation Not Yet Recruiting
NCT07534332 Disulfiram in Rheumatoid Arthritis Rheumatoid Arthritis Not Yet Recruiting
NCT07554131 Evaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia Refractory Amblyopia Not Yet Recruiting
NCT04887558 Mobile App for Smoking Cessation and Mental Health Smoking Cessation Active, Not Recruiting
NCT06660017 Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse Head and Neck Cancer Not Yet Recruiting
NCT04373642 "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer Head and Neck Cancer Active, Not Recruiting
NCT03526432 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer Endometrial Cancer Active, Not Recruiting
Phase 1
NCT03541889 REVEAL Biomarkers of Engraftment After Alternative Donor HSCT Primary Graft Failure Recruiting
NCT04928508 Advanced or Recurrent Solid Tumors Treated With SHetA2 Solid Tumor, Adult Recruiting
NCT06130995 Relugolix + Enzalutamide Study in High-Risk Prostate Cancer Androgen Deprivation Therapy Recruiting
NCT03633955 Pilot Imaging Study of Leukemia Acute Lymphocytic Leukemia Recruiting
View all 78 active University of Oklahoma trials with filters →
Disease Areas
Get alerts when University of Oklahoma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free